Alpha-1 antitrypsin deficiency as a common treatable mechanism in chronic respiratory disorders and for conditions different from pulmonary emphysema? A commentary on the new European Respiratory Society statement
Abstract Background The European Respiratory Society recently published an important statement reviewing available evidence on diagnosis and treatment of lung disease associated to alpha-1 antitrypsin deficiency (AATD). Several issues on this topic still remain unresolved and subject of interpretati...
Main Authors: | Andrea Gramegna, Stefano Aliberti, Marco Confalonieri, Angelo Corsico, Luca Richeldi, Carlo Vancheri, Francesco Blasi |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2018-10-01
|
Series: | Multidisciplinary Respiratory Medicine |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40248-018-0153-4 |
Similar Items
-
The Distribution of Alpha-1 Antitrypsin Genotypes Between Patients with COPD/Emphysema, Asthma and Bronchiectasis
by: Veith M, et al.
Published: (2020-11-01) -
Alpha 1 antitrypsin deficiency in non cystic fibrosis bronchiectasis
by: Mohamed Shahat Badawy, et al.
Published: (2013-04-01) -
Description of a new rare alpha-1 antitrypsin mutation in Naples (Italy): PI*M S-Napoli
by: Marco Mosella, et al.
Published: (2018-01-01) -
Alpha-1-Antitrypsin Deficiency and Bronchiectasis: A Concomitance or a Real Association?
by: Alessandro Sanduzzi, et al.
Published: (2020-03-01) -
"Study of α1-Antitrypsin Phenotypes Frequencies in Patients with Primary Antibody Deficiency "
by: Mohammad R. Fazlollahi, et al.
Published: (2006-06-01)